India’s Commerce and Industry Minister Piyush Goyal used meetings with Bayer and Fresenius leaders in Berlin to explore deeper healthcare ties, pointing to domestic demand, manufacturing capacity and skilled workers as areas for cooperation.
Goyal met Stefan Oelrich, head of Bayer’s Pharmaceuticals Division, to discuss the company’s expansion plans for India. He said their conversation covered ways Bayer could deepen its engagement through investment, innovation and collaboration. His post did not announce a specific commitment from the company.
In his meeting with Fresenius CEO Michael Sen, Goyal raised India’s demand for medical solutions that combine quality and affordability. He also pointed to the country’s manufacturing capabilities and discussed whether Indian talent could help Fresenius serve customers in India and other markets.
Across the two healthcare meetings, Goyal pointed to India’s market demand and production capacity; workforce potential came up in the discussion with Fresenius. His posts described areas of possible cooperation but disclosed no agreement or specific investment commitment from Bayer or Fresenius.
Goyal also met Murat Akyildiz, a Global General Partner at Knauf Group, to discuss the company’s manufacturing activity in India. They considered further cooperation on sustainable building materials and infrastructure, Goyal said. His post tied those areas to India’s urban and economic development.
The meetings took place during Goyal’s official visit to Germany from Oct. 22 to 24, followed by a Netherlands trip through Oct. 27. The government described the wider itinerary as an effort to strengthen trade, investment and industrial cooperation with both countries.
About 100 businesses and startups were expected to accompany Goyal, the government said. The delegation was scheduled to hold Berlin roundtables with German companies on healthcare, pharmaceuticals and wellness. The Netherlands leg was set to continue through Oct. 27.
